Sarcoidosis echocardiography or ultrasound: Difference between revisions
mNo edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Sarcoidosis}} | {{Sarcoidosis}} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}}Roshan Dinparasti Saleh M.D. | ||
==Overview== | ==Overview== | ||
[[Infiltrative cardiomyopathy]] caused by [[sarcoidosis]], has two major complications: [[arrhythmia]]s, and reduced [[ejection fraction]]. Therefore [[echocardiography]] and 24-48 hour [[cardiac monitoring]] are useful tests for screening of cardiac involvement. | |||
==Ultrasound== | ==Ultrasound== | ||
[[Infiltrative cardiomyopathy]] caused by [[sarcoidosis]], has two major complications: [[arrhythmia]]s, and reduced [[ejection fraction]]. Therefore [[echocardiography]] and 24-48 hour [[cardiac monitoring]] are useful tests for screening of cardiac involvement.<ref>Hamzeh NY, Wamboldt FS, Weinberger HD: Management of cardiac sarcoidosis in the United States: a Delphi study. Chest 2012, 141(1):154-162.</ref><ref>Mehta D, Lubitz SA, Frankel Z, et al: Cardiac involvement in patients | |||
with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 133(6):1426–1435, 2008.</ref> | |||
==References== | ==References== | ||
Latest revision as of 13:39, 6 May 2018
|
Sarcoidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sarcoidosis echocardiography or ultrasound On the Web |
|
American Roentgen Ray Society Images of Sarcoidosis echocardiography or ultrasound |
|
Risk calculators and risk factors for Sarcoidosis echocardiography or ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Roshan Dinparasti Saleh M.D.
Overview
Infiltrative cardiomyopathy caused by sarcoidosis, has two major complications: arrhythmias, and reduced ejection fraction. Therefore echocardiography and 24-48 hour cardiac monitoring are useful tests for screening of cardiac involvement.
Ultrasound
Infiltrative cardiomyopathy caused by sarcoidosis, has two major complications: arrhythmias, and reduced ejection fraction. Therefore echocardiography and 24-48 hour cardiac monitoring are useful tests for screening of cardiac involvement.[1][2]
References
- ↑ Hamzeh NY, Wamboldt FS, Weinberger HD: Management of cardiac sarcoidosis in the United States: a Delphi study. Chest 2012, 141(1):154-162.
- ↑ Mehta D, Lubitz SA, Frankel Z, et al: Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 133(6):1426–1435, 2008.